Document text
CCI_Lymphoma
MedDRA Dictionary Version: 230
Status: ACTIVETerm Name: CCI_LymphomaCode: 90002957Extension: CCIReport Date/Time: 27-Oct-2020:10:47:45 AM EDT
Term Code Level Category Weight Scope
Waldenstrom's macroglobulinaemia stage IV 10047809 PT
Waldenstrom's macroglobulinaemia stage III 10047808 PT
Waldenstrom's macroglobulinaemia stage II 10047807 PT
Waldenstrom's macroglobulinaemia stage I 10047806 PT
Waldenstrom's macroglobulinaemia refractory 10047805 PT
Waldenstrom's macroglobulinaemia recurrent 10047804 PT
Waldenstrom's macroglobulinaemia 10047801 PT
Thyroid B-cell lymphoma 10072613 PT
T-cell unclassifiable lymphoma low grade 10042990 PT
T-cell unclassifiable lymphoma high grade 10042989 PT
T-cell lymphoma stage IV 10042984 PT
T-cell lymphoma stage III 10042983 PT
T-cell lymphoma stage II 10042982 PT
T-cell lymphoma stage I 10042981 PT
T-cell lymphoma refractory 10042980 PT
T-cell lymphoma recurrent 10042979 PT
T-cell lymphoma 10042971 PT
Splenic marginal zone lymphoma stage IV 10041657 PT
Splenic marginal zone lymphoma stage III 10041656 PT
Splenic marginal zone lymphoma stage II 10041655 PT
Splenic marginal zone lymphoma stage I 10041654 PT
Splenic marginal zone lymphoma refractory 10041653 PT
Splenic marginal zone lymphoma recurrent 10041652 PT
Splenic marginal zone lymphoma 10062113 PT
Richter's syndrome 10058728 PT
Nodal marginal zone B-cell lymphoma recurrent 10029463 PT
Nodal marginal zone B-cell lymphoma 10029460 PT
Natural killer-cell lymphoblastic lymphoma 10058975 PT
Cutaneous T-cell lymphoma stage IV 10011683 PT
Primary mediastinal large B-cell lymphoma stage IV 10036718 PT
Primary mediastinal large B-cell lymphoma stage III 10036717 PT
Primary mediastinal large B-cell lymphoma stage II 10036716 PT
Primary mediastinal large B-cell lymphoma stage I 10036715 PT
Primary mediastinal large B-cell lymphoma refractory 10036714 PT
B-cell small lymphocytic lymphoma stage III 10003915 PT
B-cell small lymphocytic lymphoma stage II 10003914 PT
B-cell small lymphocytic lymphoma stage I 10003913 PT
090177e196edd23c\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023938
B-cell small lymphocytic lymphoma refractory 10003912 PT
B-cell small lymphocytic lymphoma recurrent 10003911 PT
B-cell small lymphocytic lymphoma 10003908 PT
B-cell prolymphocytic leukaemia 10073480 PT
B-cell lymphoma stage IV 10003907 PT
B-cell lymphoma stage III 10003906 PT
B-cell lymphoma stage II 10003905 PT
B-cell lymphoma stage I 10003904 PT
B-cell lymphoma refractory 10003903 PT
B-cell lymphoma recurrent 10003902 PT
B-cell lymphoma 10003899 PT
Angioimmunoblastic T-cell lymphoma stage IV 10002457 PT
Angioimmunoblastic T-cell lymphoma stage III 10002456 PT
Angioimmunoblastic T-cell lymphoma stage II 10002455 PT
Angioimmunoblastic T-cell lymphoma stage I 10002454 PT
Angioimmunoblastic T-cell lymphoma refractory 10002453 PT
Angioimmunoblastic T-cell lymphoma recurrent 10002452 PT
Angioimmunoblastic T-cell lymphoma 10002449 PT
Angiocentric lymphoma stage IV 10002419 PT
Angiocentric lymphoma stage III 10002418 PT
Angiocentric lymphoma stage II 10002417 PT
Primary mediastinal large B-cell lymphoma recurrent 10036713 PT
Primary mediastinal large B-cell lymphoma 10036710 PT
Primary effusion lymphoma 10065857 PT
Primary cardiac lymphoma 10075993 PT
Precursor T-lymphoblastic lymphoma/leukaemia stage IV 10036551 PT
Precursor T-lymphoblastic lymphoma/leukaemia stage III 10036550 PT
Precursor T-lymphoblastic lymphoma/leukaemia stage II 10036549 PT
Precursor T-lymphoblastic lymphoma/leukaemia stage I 10036548 PT
Precursor T-lymphoblastic lymphoma/leukaemia refractory 10036547 PT
Precursor T-lymphoblastic lymphoma/leukaemia recurrent 10036546 PT
Precursor T-lymphoblastic lymphoma/leukaemia 10036543 PT
Precursor B-lymphoblastic lymphoma stage IV 10036535 PT
Precursor B-lymphoblastic lymphoma stage III 10036534 PT
Precursor B-lymphoblastic lymphoma stage II 10036533 PT
Precursor B-lymphoblastic lymphoma stage I 10036532 PT
Precursor B-lymphoblastic lymphoma refractory 10060911 PT
Precursor B-lymphoblastic lymphoma recurrent 10060910 PT
Precursor B-lymphoblastic lymphoma 10036523 PT
Plasmablastic lymphoma 10065039 PT
Peripheral T-cell lymphoma unspecified stage IV 10034630 PT
Peripheral T-cell lymphoma unspecified stage III 10034629 PT
Peripheral T-cell lymphoma unspecified stage II 10034628 PT
Peripheral T-cell lymphoma unspecified stage I 10034627 PT
Peripheral T-cell lymphoma unspecified refractory 10034626 PT
Peripheral T-cell lymphoma unspecified recurrent 10034625 PT
Follicle centre lymphoma diffuse small cell lymphoma recurrent 10016897 PT
Follicle centre lymphoma diffuse small cell lymphoma 10061957 PT
Extranodal marginal zone B-cell lymphoma (MALT type) stage IV 10015828 PTExtranodal marginal zone B-cell lymphoma (MALT type) stage III 10015827 PT
Extranodal marginal zone B-cell lymphoma (MALT type) stage II 10015826 PT
Extranodal marginal zone B-cell lymphoma (MALT type) stage I 10015825 PT
Non-Hodgkin's lymphoma unspecified histology indolent 10065856 PT
090177e196edd23c\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023939
Non-Hodgkin's lymphoma unspecified histology aggressive stage IV 10029614 PT
Non-Hodgkin's lymphoma unspecified histology aggressive stage III 10029613 PTNon-Hodgkin's lymphoma unspecified histology aggressive stage II 10029612 PT
Non-Hodgkin's lymphoma unspecified histology aggressive stage I 10029611 PT
Non-Hodgkin's lymphoma unspecified histology aggressive refractory 10029610 PTNon-Hodgkin's lymphoma unspecified histology aggressive recurrent 10029609 PTNon-Hodgkin's lymphoma unspecified histology aggressive 10063908 PT
Non-Hodgkin's lymphoma transformed recurrent 10061871 PTNon-Hodgkin's lymphoma stage IV 10029605 PTNon-Hodgkin's lymphoma stage III 10029604 PTNon-Hodgkin's lymphoma stage II 10029603 PTNon-Hodgkin's lymphoma stage I 10029602 PTNon-Hodgkin's lymphoma refractory 10029601 PTNon-Hodgkin's lymphoma recurrent 10029600 PTNon-Hodgkin's lymphoma 10029547 PTNodal marginal zone B-cell lymphoma stage IV 10029468 PTNodal marginal zone B-cell lymphoma stage III 10029467 PTNodal marginal zone B-cell lymphoma stage II 10029466 PTNodal marginal zone B-cell lymphoma stage I 10029465 PTNodal marginal zone B-cell lymphoma refractory 10029464 PTHodgkin's disease mixed cellularity stage IV 10020241 PTHodgkin's disease mixed cellularity stage III 10020240 PTHodgkin's disease mixed cellularity stage II supradiaphragmatic 10020239 PT
Cutaneous T-cell lymphoma stage III 10011682 PTCutaneous T-cell lymphoma stage II 10011681 PTCutaneous T-cell lymphoma stage I 10011680 PTCutaneous T-cell lymphoma refractory 10011679 PTCutaneous T-cell lymphoma recurrent 10011678 PTCutaneous T-cell lymphoma 10011677 PTMarginal zone lymphoma stage IV 10077532 PTMarginal zone lymphoma stage III 10077531 PTMarginal zone lymphoma stage II 10077530 PTMarginal zone lymphoma stage I 10077529 PTMarginal zone lymphoma refractory 10077534 PTMarginal zone lymphoma recurrent 10077533 PTMarginal zone lymphoma 10076596 PTMantle cell lymphoma stage IV 10026805 PTMantle cell lymphoma stage III 10026804 PTMantle cell lymphoma stage II 10026803 PTMantle cell lymphoma stage I 10026802 PTMantle cell lymphoma refractory 10026801 PTMantle cell lymphoma recurrent 10026800 PTMantle cell lymphoma 10061275 PTMalignant lymphoma unclassifiable low grade 10025636 PTMalignant lymphoma unclassifiable high grade 10025635 PTMalignant lymphoid neoplasm 10061240 PTLymphoproliferative disorder in remission 10061233 PTLymphoproliferative disorder 10061232 PTLymphoplasmacytoid lymphoma/immunocytoma stage IV 10025350 PTLymphoplasmacytoid lymphoma/immunocytoma stage III 10025349 PTLymphoplasmacytoid lymphoma/immunocytoma stage II 10025348 PTLymphoplasmacytoid lymphoma/immunocytoma stage I 10025347 PTLymphoplasmacytoid lymphoma/immunocytoma refractory 10025346 PT
090177e196edd23c\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023940
Lymphoplasmacytoid lymphoma/immunocytoma recurrent 10025345 PT
Lymphoplasmacytoid lymphoma/immunocytoma 10025342 PT
Lymphoma transformation 10064344 PT
Cutaneous lymphoma 10079945 PT
Lymphoma 10025310 PT
Lymphocytic lymphoma 10052178 PT
Leukaemic lymphoma 10024325 PT
Intestinal T-cell lymphoma stage IV 10022711 PT
Intestinal T-cell lymphoma stage III 10022710 PT
Intestinal T-cell lymphoma stage II 10022709 PT
Intestinal T-cell lymphoma stage I 10022708 PT
Intestinal T-cell lymphoma refractory 10022707 PT
Extranodal marginal zone B-cell lymphoma (MALT type) refractory 10015824 PT
Extranodal marginal zone B-cell lymphoma (MALT type) recurrent 10015823 PTExtranodal marginal zone B-cell lymphoma (MALT type) 10061850 PT
Epstein-Barr virus associated lymphoma 10071441 PT
Enteropathy-associated T-cell lymphoma 10073481 PT
Disseminated large cell lymphoma 10054951 PT
Diffuse large B-cell lymphoma stage IV 10012826 PT
Diffuse large B-cell lymphoma stage III 10012825 PT
Diffuse large B-cell lymphoma stage II 10012824 PT
Diffuse large B-cell lymphoma stage I 10012823 PT
Diffuse large B-cell lymphoma refractory 10012822 PT
Diffuse large B-cell lymphoma recurrent 10012821 PT
Diffuse large B-cell lymphoma 10012818 PT
Composite lymphoma 10073957 PT
Central nervous system lymphoma 10007953 PT
Burkitt's lymphoma stage IV 10006603 PT
Burkitt's lymphoma stage III 10006602 PT
Burkitt's lymphoma stage II 10006601 PT
Burkitt's lymphoma stage I 10006600 PT
Burkitt's lymphoma refractory 10006599 PT
Burkitt's lymphoma recurrent 10006598 PT
Burkitt's lymphoma 10006595 PT
Blastic plasmacytoid dendritic cell neoplasia 10075460 PT
B-cell unclassifiable lymphoma low grade 10003923 PT
B-cell unclassifiable lymphoma high grade 10003922 PT
B-cell small lymphocytic lymphoma stage IV 10003916 PT
Peripheral T-cell lymphoma unspecified 10034623 PT
Ocular lymphoma 10075324 PT
Non-Hodgkin's lymphoma unspecified histology indolent stage IV 10029625 PTNon-Hodgkin's lymphoma unspecified histology indolent stage III 10029624 PTNon-Hodgkin's lymphoma unspecified histology indolent stage II 10029623 PTNon-Hodgkin's lymphoma unspecified histology indolent stage I 10029622 PTIntestinal T-cell lymphoma recurrent 10022706 PT
Immunoblastic lymphoma 10053574 PT
Hodgkin's disease unclassifiable 10020271 PT
Hodgkin's disease stage IV 10061597 PT
Hodgkin's disease stage III 10020270 PT
Hodgkin's disease stage II 10020269 PTHodgkin's disease stage I 10020268 PTHodgkin's disease refractory 10020267 PTHodgkin's disease recurrent 10020266 PT
090177e196edd23c\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023941
Hodgkin's disease nodular sclerosis stage IV 10020253 PT
Hodgkin's disease nodular sclerosis stage III 10020252 PT
Hodgkin's disease nodular sclerosis stage II 10073534 PT
Hodgkin's disease nodular sclerosis stage I 10073535 PT
Hodgkin's disease nodular sclerosis refractory 10020246 PTHodgkin's disease nodular sclerosis recurrent 10020245 PTHodgkin's disease nodular sclerosis 10020244 PTHodgkin's disease mixed cellularity stage unspecified 10020242 PTHodgkin's disease mixed cellularity stage II subdiaphragmatic 10020238 PT
Hodgkin's disease mixed cellularity stage I supradiaphragmatic 10020237 PT
Hodgkin's disease mixed cellularity stage I subdiaphragmatic 10020236 PT
Hodgkin's disease mixed cellularity stage I site unspecified 10020235 PTHodgkin's disease mixed cellularity refractory 10020234 PTHodgkin's disease mixed cellularity recurrent 10020233 PTHodgkin's disease lymphocyte predominance type stage unspecified 10020231 PTHodgkin's disease lymphocyte predominance type stage IV 10020230 PT
Hodgkin's disease lymphocyte predominance type stage III 10020229P T
Hodgkin's disease lymphocyte predominance type refractory 10020228 PT
Hodgkin's disease lymphocyte predominance type recurrent 1002022 7P T
Hodgkin's disease lymphocyte predominance stage II supradiaphragm 10020225 PTHodgkin's disease lymphocyte predominance stage II subdiaphragm 10020224 PT
Hodgkin's disease lymphocyte predominance stage II site unspec 10020223 PT
Hodgkin's disease lymphocyte predominance stage I supradiaphragm 10020222 PTHodgkin's disease lymphocyte predominance stage I subdiaphragm 10020221 PTHodgkin's disease lymphocyte predominance stage I site unspec 10020220 PT
Hodgkin's disease lymphocyte depletion type stage unspecified 10020219 PT
Hodgkin's disease lymphocyte depletion type stage IV 10020218 PTHodgkin's disease lymphocyte depletion type stage III 10020217 PTHodgkin's disease lymphocyte depletion type refractory 10020216 PTHodgkin's disease lymphocyte depletion type recurrent 10020215 PTHodgkin's disease lymphocyte depletion stage II supradiaphragm 10020213 PTHodgkin's disease lymphocyte depletion stage II subdiaphragm 10020212 PT
Hodgkin's disease lymphocyte depletion stage II site unspecified 10020211 PT
Hodgkin's disease lymphocyte depletion stage I supradiaphragm 10020210 PTHodgkin's disease lymphocyte depletion stage I subdiaphragm 10020209 PT
Hodgkin's disease lymphocyte depletion stage I site unspecified 10020208 PT
Hodgkin's disease 10020206 PTHigh grade B-cell lymphoma Burkitt-like lymphoma stage IV 10020075 PTHigh grade B-cell lymphoma Burkitt-like lymphoma stage III 10020074 PTHigh grade B-cell lymphoma Burkitt-like lymphoma stage II 10020073 PTHigh grade B-cell lymphoma Burkitt-like lymphoma stage I 1002007 2P T
High grade B-cell lymphoma Burkitt-like lymphoma refractory 10020071 PTHigh grade B-cell lymphoma Burkitt-like lymphoma recurrent 10020070 PTAngiocentric lymphoma stage I 10002416 PTAngiocentric lymphoma refractory 10002415 PTAngiocentric lymphoma recurrent 10002414 PTAngiocentric lymphoma 10002411 PTAnaplastic large-cell lymphoma 10073478 PTAnaplastic large cell lymphoma T- and null-cell types stage IV 10002234 PTAnaplastic large cell lymphoma T- and null-cell types stage III 10002233 PT
Anaplastic large cell lymphoma T- and null-cell types stage II 10002232 PTAnaplastic large cell lymphoma T- and null-cell types stage I 10002231 PTAnaplastic large cell lymphoma T- and null-cell types refractory 10002230 PT
090177e196edd23c\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023942
Anaplastic large cell lymphoma T- and null-cell types recurrent 10002229 PT
Anaplastic large cell lymphoma T- and null-cell types 10002227 PT
Adult T-cell lymphoma/leukaemia stage IV 10001421 PTAdult T-cell lymphoma/leukaemia stage III 10001420 PTAdult T-cell lymphoma/leukaemia stage II 10001419 PTAdult T-cell lymphoma/leukaemia stage I 10001418 PTAdult T-cell lymphoma/leukaemia refractory 10001417 PTAdult T-cell lymphoma/leukaemia recurrent 10001416 PTAdult T-cell lymphoma/leukaemia 10001413 PTHigh grade B-cell lymphoma Burkitt-like lymphoma 10020067 PTHepatosplenic T-cell lymphoma 10066957 PTFollicle centre lymphoma, follicular grade I, II, III stage IV 10016910 PT
Follicle centre lymphoma, follicular grade I, II, III stage III 10016909 PT
Follicle centre lymphoma, follicular grade I, II, III stage II 10016908 PT
Follicle centre lymphoma, follicular grade I, II, III stage I 10016907 PT
Follicle centre lymphoma, follicular grade I, II, III refractory 10016906 PT
Follicle centre lymphoma, follicular grade I, II, III recurrent 10016905 PT
Follicle centre lymphoma, follicular grade I, II, III 10061170 PT
Follicle centre lymphoma diffuse small cell lymphoma stage IV 10016902 PT
Follicle centre lymphoma diffuse small cell lymphoma stage III 10016901 PT
Follicle centre lymphoma diffuse small cell lymphoma stage II 10016900 PT
Follicle centre lymphoma diffuse small cell lymphoma stage I 10016899 PT
Follicle centre lymphoma diffuse small cell lymphoma refractory 10016898 PT
090177e196edd23c\Final\Final On: 01-May-2021 00:12 (GMT)
FDA-CBER-2021-5683-0023943